Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 75051782 | 7505178 | 2 | F | 20100622 | 20121219 | 20100728 | 20121231 | EXP | US-BRISTOL-MYERS SQUIBB COMPANY-15182231 | BRISTOL MYERS SQUIBB | 58.00 | YR | M | Y | 86.50000 | KG | 20121231 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 75051782 | 7505178 | 1 | PS | CETUXIMAB | 1 | INTRAVENOUS | RECENT INF:18JUN10,INF:5 | U | 3139822 | 0 | 537.5 | MG | /wk | ||||||
| 75051782 | 7505178 | 2 | SS | CISPLATIN FOR INJ | 1 | INTRAVENOUS | RECENT INF:18JUN10, INF:2 CAPS | U | 0 | 120.94 | MG | Q3W | |||||||
| 75051782 | 7505178 | 3 | SS | GEMCITABINE | 1 | INTRAVENOUS | RECENT INF:18JUN10,INF:3 | U | 0 | 1612.5 | MG | ||||||||
| 75051782 | 7505178 | 4 | C | K-DUR | 1 | UNKNOWN | D | 0 | 20 | MEQ | QD | ||||||||
| 75051782 | 7505178 | 5 | C | LASIX | 1 | UNKNOWN | D | 0 | 20 | MG | BID | ||||||||
| 75051782 | 7505178 | 6 | C | OXYCONTIN | 1 | UNKNOWN | DOSAGE:2-3 HRS AS NEEDED. | D | 0 | 5 | MG | ||||||||
| 75051782 | 7505178 | 7 | C | ATIVAN | 1 | UNKNOWN | DOSAGE:PER 6 HR AS NEEDED. | D | 0 | .5 | MG | ||||||||
| 75051782 | 7505178 | 8 | C | COLACE | 1 | UNKNOWN | DOSAGE:2 IN 1 DAY PRN. | D | 0 | 100 | MG | ||||||||
| 75051782 | 7505178 | 9 | C | MIRALAX | 1 | UNKNOWN | D | 0 | 17 | G | BID | ||||||||
| 75051782 | 7505178 | 10 | C | ZOFRAN | 1 | UNKNOWN | DOSAGE: PER 8 HR/PRN. | D | 0 | 8 | MG | ||||||||
| 75051782 | 7505178 | 11 | C | COMPAZINE | 1 | UNKNOWN | DOSAGE:PER 8HR/PRN. | D | 0 | 10 | MG | ||||||||
| 75051782 | 7505178 | 12 | C | LIPITOR | 1 | UNKNOWN | D | 0 | 80 | MG | QD | ||||||||
| 75051782 | 7505178 | 13 | C | ZETIA | 1 | UNKNOWN | D | 0 | 10 | MG | QD | ||||||||
| 75051782 | 7505178 | 14 | C | MULTIVITAMINS | 1 | UNKNOWN | D | 0 | 1 | DF | QD | ||||||||
| 75051782 | 7505178 | 15 | C | HYDROCODONE + ACETAMINOPHEN | 1 | UNKNOWN | 1 DF:1-2 TABS 4-6HRS AS NEEDED. | D | 0 | 1 | DF | ||||||||
| 75051782 | 7505178 | 16 | C | ORAMORPH | 1 | UNKNOWN | D | 0 | 100 | MG | TID | ||||||||
| 75051782 | 7505178 | 17 | C | AMBIEN | 1 | UNKNOWN | DOSAGE:AT NIGHT DAILY. | D | 0 | 10 | MG | ||||||||
| 75051782 | 7505178 | 18 | C | LOVENOX | 1 | SUBCUTANEOUS | D | 0 | 90 | MG | BID | ||||||||
| 75051782 | 7505178 | 19 | C | KEFLEX | 1 | UNKNOWN | D | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 75051782 | 7505178 | 1 | Non-small cell lung cancer metastatic |
| 75051782 | 7505178 | 2 | Non-small cell lung cancer metastatic |
| 75051782 | 7505178 | 3 | Non-small cell lung cancer metastatic |
| 75051782 | 7505178 | 12 | Hyperlipidaemia |
| 75051782 | 7505178 | 13 | Hyperlipidaemia |
| 75051782 | 7505178 | 19 | Cellulitis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 75051782 | 7505178 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 75051782 | 7505178 | Dyspnoea | |
| 75051782 | 7505178 | Malignant pleural effusion |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 75051782 | 7505178 | 1 | 20100521 | 0 | ||
| 75051782 | 7505178 | 2 | 20100524 | 201006 | 0 | |
| 75051782 | 7505178 | 3 | 20100521 | 0 | ||
| 75051782 | 7505178 | 19 | 201006 | 201006 | 0 |